Effect of Intravenous Fructose 1,6-Diphosphate Administration in Malnourished Chronic Obstructive Pulmonary Disease Patients with Chronic Respiratory Failure

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Respiration

• Publication date

  2000-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000029483PMID 10773790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease.

  2015cited by this paper
• Respiratory muscle strength and maximal voluntary ventilation in undernourished patients.

  2015cited by this paper
• Fructose-1,6-bisphosphate as a metabolic substrate in hog ileum smooth muscle during hypoxia.

  1996cited by this paper
• Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society.

  1995cited by this paper
• Metabolism of exogenously applied fructose 1,6-bisphosphate in hypoxic vascular smooth muscle.

  1994cited by this paper
• Pulmonary rehabilitation that includes arm exercise reduces metabolic and ventilatory requirements for simple arm elevation.

  1993cited by this paper
• Operationalizing dyspnea: focus on measurement.

  1992cited by this paper
• Hypophosphatemia in course of chronic obstructive pulmonary disease. Prevalence, mechanisms, and relationships with skeletal muscle phosphorus content.

  1990cited by this paper
• Muscle wasting in emphysema.

  1988cited by this paper
• Hypophosphatemia-associated respiratory muscle weakness in a general inpatient population.

  1988cited by this paper
• Determinants of respiratory muscle failure.

  1986cited by this paper
• Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure.

  1985cited by this paper
• Nutrition and chronic lung disease.

  1985cited by this paper
• Metabolic effects of fructose diphosphate in hypoxic and ischemic states.

  1984cited by this paper
• Skeletal muscle cell abnormalities in acute hypophosphatemia during total parenteral nutrition.

  1984cited by this paper
• Metabolic effects of fructose diphosphate in hypoxic and ischemic states.

  1984cited by this paper
• Neuromuscular manifestations of electrolyte disorders.

  1982cited by this paper
• Effects of hypophosphatemia on pulmonary muscle performance.

  1982cited by this paper
• Preservation of myocardium by infusion of fructose diphosphate following coronary occlusion

  1982cited by this paper
• Reversible depression in myocardial performance in dogs with experimental phosphorus deficiency.

  1978cited by this paper
• Diaphragm and body weight in emphysema.

  1978cited by this paper
• Acute respiratory failure associated with hypophosphatemia.

  1977cited by this paper
• The pathophysiology and clinical characteristics of severe hypophosphatemia.

  1977cited by this paper
• Protein turnover in skeletal muscle. II. Effects of denervation and cortisone on protein catabolism in skeletal muscle.

  1969cited by this paper
• Maximal respiratory pressures: normal values and relationship to age and sex.

  1969cited by this paper
• Erythrocyte adenosine triphosphate depletion during hypophosphatemia in a uremic subject.

  1969cited by this paper
• Chronic obstructive bronchopulmonary disease. II. Oxygen transport in two clinical types.

  1968cited by this paper
• A clinical method for assessing the ventilatory response to carbon dioxide.

  1967cited by this paper
• Weight changes in the terminal stages of chronic obstructive pulmonary disease. Relation to respiratory function and prognosis.

  1967cited by this paper

• Evaluation of respiratory muscle training interventions on pulmonary function in critical care: a systematic review and meta-analysis

  2025cites this paper
• Role of nutrition in patients with coexisting chronic obstructive pulmonary disease and sarcopenia

  2023cites this paper
• Fructose 1,6-Bisphosphate: A Summary of Its Cytoprotective Mechanism.

  2016cites this paper
• EVALUATING THE EFFECTIVENESS OF FRUCTOSE-1,6-DIPHOSPHATE IN TREATING OF OCULAR ISCHEMIC SYNDROME

  2015cites this paper
• Nutritional support and functional capacity in chronic obstructive pulmonary disease: A systematic review and meta‐analysis

  2013cites this paper
• Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis.

  2012cites this paper
• Reversal of Chronic Obstructive Pulmonary Disease-Associated Weight Loss

  2012cites this paper
• Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis 1-3

  2012cites this paper
• SOPORTE NUTRICIONAL EN ENFERMEDAD PULMONAR: UNA REVISIÓN SISTEMÁTICA

  2010cites this paper
• Serum phosphate in older people

  2009cites this paper
• Associations and consequences of hypophosphataemia in older hospitalised women.

  2008cites this paper
• Respiratory and skeletal muscles in chronic obstructive pulmonary disease

  2006cites this paper
• Symptom Control in Palliative Care—Part III: Dyspnea and Delirium

  2006cites this paper
• Drugs in Clinical Development for Chronic Obstructive Pulmonary Disease

  2005influential citation
• Physiological effects of intravenous fructose 1.6-diphosphate on diaphragmatic function in malnourished patients with COPD.

  2004cites this paper
• Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath.

  2002cites this paper
• Phosphate supplementation for hypophosphataemia and parenteral nutrition

  2001cites this paper